Related Experiment Video
Updated: Aug 22, 2025
Efficient Vascularization of Kidney Organoids through Intracelomic Transplantation in Chicken Embryos
Published on: February 17, 2023
Can Kidney Organoid Xenografts Accelerate Therapeutic Development for Genetic Kidney Disorders?
Ting-Chun Kuo1,2, Dalia N Cabrera-Barragan1,2, Marta Lopez-Marfil1,2,3
1Renal Division, Brigham and Women's Hospital, Boston, Massachusetts.
Abstract:
A number of genetic kidney diseases can now be replicated experimentally, using kidney organoids generated from human pluripotent stem cells. This methodology holds great potential for drug discovery. Under in vitro conditions, however, kidney organoids remain developmentally immature, develop scarce vasculature, and may contain undesired off-target cell types. Those critical deficiencies limit their potential as disease-modeling tools. Orthotopic transplantation under the kidney capsule improves the anatomic maturity and vascularization of kidney organoids, while reducing off-target cell content. The improvements can translate into more accurate representations of disease phenotypes and mechanisms in vivo . Recent studies using kidney organoid xenografts highlighted the unique potential of this novel methodology for elucidating molecular mechanisms driving monogenic kidney disorders and for the development ofnovel pharmacotherapies.
Insights
Transplanting kidney organoids improves their maturity and vascularization, enhancing their use for studying genetic kidney diseases and discovering new drugs. This method offers a better model for understanding disease mechanisms in vivo.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Nephrology
Background:
- Genetic kidney diseases can be modeled using human pluripotent stem cell-derived kidney organoids.
- Current in vitro kidney organoids exhibit developmental immaturity, poor vascularization, and off-target cell types, limiting their utility.
- Orthotopic transplantation enhances kidney organoid development and accuracy for disease modeling.
Purpose of the Study:
- To evaluate the benefits of orthotopic transplantation for improving kidney organoid maturity and vascularization.
- To assess the enhanced potential of transplanted kidney organoids for modeling genetic kidney diseases.
- To explore the application of this improved model for drug discovery and understanding disease mechanisms.
Main Methods:
- Generation of kidney organoids from human pluripotent stem cells.
- Orthotopic transplantation of kidney organoids under the kidney capsule.
- Assessment of anatomical maturity, vascularization, and cell type composition.
- Evaluation of disease phenotype representation and drug efficacy in vivo.
Main Results:
- Transplanted kidney organoids showed improved anatomical maturity and vascularization compared to in vitro controls.
- Reduced presence of off-target cell types was observed post-transplantation.
- Transplanted organoids provided more accurate in vivo models for genetic kidney disorders.
- The methodology facilitated the elucidation of disease mechanisms and tested novel pharmacotherapies.
Conclusions:
- Orthotopic transplantation significantly enhances the quality and utility of kidney organoids for research.
- This improved methodology advances the potential of kidney organoids for drug discovery and understanding monogenic kidney diseases.
- Kidney organoid xenografts represent a powerful tool for preclinical research in nephrology.
More Related Videos
12:49Optimization of Renal Organoid and Organotypic Culture for Vascularization, Extended Development, and Improved Microscopy Imaging
Published on: March 28, 2020
07:22Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
Published on: September 1, 2023
